Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2000-9-14
pubmed:abstractText
The relative risk of development of peptic ulcer with the use of nonsteroidal antiinflammatory drugs (NSAIDs) has been reported to increase when these drugs are administered in combination with steroids. We investigated the ulcerogenic potential of a combination of NSAIDs and steroids in rats and the underlying pathogenic mechanisms. Indomethacin alone produced gastric lesions, and the severity of the lesions markedly increased with concomitant administration of prednisolone. However, nimesulide, even in excessive doses, did not produce any gastric lesions, regardless of concomitant administration with prednisolone. Furthermore, we showed that the ulcerogenic potential of indomethacin administered in combination with prednisolone may be related to the induction of physiological changes, such as endogenous prostaglandin deficiency, an increase in neutrophil activation, and gastric hypermotility, by indomethacin and alteration of normal epithelial renewal by the steroid. These results suggest that the ulcerogenic potential of preferential a COX-1 inhibitor increases following concomitant administration with a steroid, whereas, nimesulide, a preferential COX-2 inhibitor, is nonulcerogenic, even when administered concomitantly with a steroid, and is therefore a clinically useful antiinflammatory agent.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Peroxidase, http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases, http://linkedlifedata.com/resource/pubmed/chemical/Ptgs1 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/nimesulide
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0163-2116
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1366-75
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:10961716-Animals, pubmed-meshheading:10961716-Anti-Inflammatory Agents, pubmed-meshheading:10961716-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:10961716-Cyclooxygenase 1, pubmed-meshheading:10961716-Cyclooxygenase 2, pubmed-meshheading:10961716-Cyclooxygenase 2 Inhibitors, pubmed-meshheading:10961716-Cyclooxygenase Inhibitors, pubmed-meshheading:10961716-DNA, pubmed-meshheading:10961716-Drug Interactions, pubmed-meshheading:10961716-Drug Synergism, pubmed-meshheading:10961716-Gastric Mucosa, pubmed-meshheading:10961716-Gastrointestinal Motility, pubmed-meshheading:10961716-Indomethacin, pubmed-meshheading:10961716-Isoenzymes, pubmed-meshheading:10961716-Male, pubmed-meshheading:10961716-Membrane Proteins, pubmed-meshheading:10961716-Peroxidase, pubmed-meshheading:10961716-Prednisolone, pubmed-meshheading:10961716-Prostaglandin-Endoperoxide Synthases, pubmed-meshheading:10961716-Rats, pubmed-meshheading:10961716-Rats, Wistar, pubmed-meshheading:10961716-Stomach, pubmed-meshheading:10961716-Stomach Ulcer, pubmed-meshheading:10961716-Sulfonamides
pubmed:year
2000
pubmed:articleTitle
Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach.
pubmed:affiliation
Osaka Research Laboratory, Sawai Pharmaceutical Co., LTD, Japan.
pubmed:publicationType
Journal Article